Johns Hopkins researchers helped secure full FDA approval to treat immunocompromised COVID-19 patients—paving the way to ...

Invivyd (IVVD) announced positive data from its ongoing Phase 1/2 clinical trial of VYD2311, Invivyd’s novel monoclonal antibody candidate ...

A new antibody therapy effectively protects monkeys from severe H5N1 avian flu, offering hope for a universal flu vaccine and ...